Christine M. Albert, MD, MPH
Professor of Medicine, Harvard Medical School
Physician, Brigham and Women’s Hospital
calbert@bwh.harvard.edu
Dr. Albert is the Director of the Center for Arrhythmia Prevention at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. Dr. Albert received her MD from Harvard Medical School and MPH from the Harvard School of Public Health. She completed her Internal Medicine, Cardiology, and Cardiac Electrophysiology training at the Massachusetts General Hospital in Boston. She currently holds joint appointments as a clinical cardiac electrophysiologist and epidemiologist within the Divisions of Cardiovascular and Preventive Medicine at Brigham and Women’s Hospital. Dr. Albert is currently the Principal Investigator on two NIH-sponsored R01s, and her research focuses on epidemiology, risk stratification, and prevention of sudden cardiac death and atrial fibrillation in large prospective cohort designs and in multi-center clinical studies, most notably seminal contributions regarding the contribution of diet, lifestyle, and genetics to the burden of heart rhythm disorders. Dr. Albert serves on the editorial boards of Heart Rhythm and is the President-Elect of the Heart Rhythm Society. Effective September 1, 2019, Dr. Albert has joined Cedars-Sinai Medical Center as the founding Chair of the Department of Cardiology and the Lee and Harold Kapelovitz Endowed Chair in Research Cardiology.
BA: Boston University
MD: Harvard Medical School
MPH: Harvard School of Public Health
Full Listing of Publications
- Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testing November 1, 2024CONCLUSION: Clinical RNA-seq can clarify VUS, especially splice variants, but laboratory-specific interpretation guidelines may lead to indeterminate results. Identifying individuals likely to benefit from RNA-seq and providing appropriate counseling poses unique challenges.Jonathan Marquez
- Oral Anticoagulation in Device Patients With Atrial High-Rate Episodes: Shared Decision-Making After ARTESIA and NOAH-AFNET-6 October 28, 2024No abstractChristine M Albert
- Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height October 3, 2024The role of rare non-coding variation in complex human phenotypes is still largely unknown. To elucidate the impact of rare variants in regulatory elements, we performed a whole-genome sequencing association analysis for height using 333,100 individuals from three datasets: UK Biobank (N = 200,003), TOPMed (N = 87,652) and All of Us (N = 45,445). […]Gareth Hawkes
- Diet and risk of atrial fibrillation: a systematic review September 17, 2024Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia. Comprehensive modification of established AF risk factors combined with dietary interventions and breaking deleterious habits has been shown to reduce AF burden and recurrence. Numerous AF risk factors, such as diabetes, obesity or hypertension can be partially related to dietary and lifestyle choices. Therefore, dietary […]Monika Gawałko
- Complete genome sequence of <em>Deinococcus sonorensis</em> type strain KR-87: a rare biofilm-producing representative of the genus <em>Deinococcus</em> September 16, 2024Here, we present a complete genome of Deinococcus sonorensis KR-87^(T), a biofilm-producing mesophile from the Arizonan Sonoran Desert. The sequence, assembled using Oxford Nanopore Technologies' long-read sequencing platform, predicts a genome size of 4.78 Mbp, with 6 replicons, 4,361 protein-coding genes, and a G+C content of 69.0%.Leilani S Boren